Rapid Onsite Cytopathologic Evaluation for Improved Molecular Marker Testing via Endobronchial Ultrasound Bronchoscopy - A Randomized Controlled Trial

Sponsor:

Johns Hopkins University (JHU)

Sponsor Study ID:

103940

CTO #:

103940

NCT Number:

NCT04945317

Phase:

N/A

Protocol Type:

Basic Science

Age Group:

Adults

Disease Sites:

Lung

Study Objectives:

The primary objective of this study is to compare Next Generation Sequencing (NGS) biomarker sufficiency among patients with known or suspected Non-Small Cell Lung Cancer (NSCLC) undergoing bronchoscopy with endobronchial ultrasound (EBUS). NGS biomarker sufficiency will be compared across four randomized arms (1:1:1:1 randomization): With ROSE and Tissue Clot Prep (RC) With ROSE and Liquid Prep (RL) Without ROSE and Tissue Clot Prep (NC) Without ROSE and Liquid Prep (NL)

eConsent:

Not available

Study Documents:

Open Study Documents
(MUSC NetID required for document access)